Cargando…

Big Endothelin-1 as a Predictor of Reverse Remodeling and Prognosis in Dilated Cardiomyopathy

This study aimed to investigate the predictive value of Big endothelin-1(ET-1) for left ventricular reverse remodeling (LVRR) and prognosis in patients with dilated cardiomyopathy (DCM). Patients with DCM and a left ventricular ejection fraction (LVEF) ≤ 50% from 2008 to 2017 were included. LVRR was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Jiayu, Liang, Lin, Chen, Yuyi, Tian, Pengchao, Zhao, Xuemei, Huang, Boping, Wu, Yihang, Wang, Jing, Guan, Jingyuan, Huang, Liyan, Li, Xinqing, Zhang, Yuhui, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967115/ https://www.ncbi.nlm.nih.gov/pubmed/36835899 http://dx.doi.org/10.3390/jcm12041363

Ejemplares similares

sST2 and Big ET-1 as Alternatives of Multi-Biomarkers Strategies for Prognosis Evaluation in Patients Hospitalized with Heart Failure
por: Chen, Yuyi, et al.
Publicado: (2023)

Outcome and prognostic value of N‐terminal pro‐brain natriuretic peptide and high‐sensitivity C‐reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy
por: Feng, Jiayu, et al.
Publicado: (2022)

Afterload-related cardiac performance is a powerful hemodynamic predictor of mortality in patients with chronic heart failure
por: Wu, Yihang, et al.
Publicado: (2023)

Combined use of right ventricular coupling and pulmonary arterial elastance as a comprehensive stratification approach for right ventricular function
por: Wu, Yihang, et al.
Publicado: (2023)

Incorporating inflammatory biomarkers into a prognostic risk score in patients with non-ischemic heart failure: a machine learning approach
por: Feng, Jiayu, et al.
Publicado: (2023)

Clinical Profile, Treatment, and Prognosis of Left Ventricular Thrombus in Dilated Cardiomyopathy
por: Huang, Liyan, et al.
Publicado: (2023)

Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failure
por: Liang, Lin, et al.
Publicado: (2022)

Prognostic value of high‐sensitivity cardiac troponin I in patients with non‐ischaemic heart failure: insights from China
por: Tian, Pengchao, et al.
Publicado: (2022)

Predictive value of remnant cholesterol level for all-cause mortality in heart failure patients
por: Zhao, Lang, et al.
Publicado: (2023)

Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives
por: Merlo, M., et al.
Publicado: (2018)

Machine Learning for Mortality Prediction in Patients With Heart Failure With Mildly Reduced Ejection Fraction
por: Tian, Pengchao, et al.
Publicado: (2023)

The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy
por: Kan, Ao, et al.
Publicado: (2023)

Clinical characteristics of patients with heart failure and intracardiac thrombus
por: Zhai, Mei, et al.
Publicado: (2022)

Hypoparathyroidism and reversible dilated cardiomyopathy
por: Babu, M. Suresh, et al.
Publicado: (2011)

Myocardial remodelling and recovery in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Electrical Ventricular Remodeling in Dilated Cardiomyopathy
por: Mages, Christine, et al.
Publicado: (2021)

Higher Serum Lysophosphatidic Acids Predict Left Ventricular Reverse Remodeling in Pediatric Dilated Cardiomyopathy
por: Wen, Haichu, et al.
Publicado: (2021)

Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy
por: Fan, Peng, et al.
Publicado: (2021)

Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling
por: Cannata, Antonio, et al.
Publicado: (2020)

A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy
por: Kimura, Yuki, et al.
Publicado: (2021)

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
por: Díez-López, Carles, et al.
Publicado: (2022)

Hyponatremia and lower normal serum sodium levels are associated with an increased risk of all‐cause death in heart failure patients
por: Zhao, Lang, et al.
Publicado: (2023)

Reversible dilated cardiomyopathy caused by hypothyroidism
por: Khochtali, I, et al.
Publicado: (2011)

Sheehan syndrome with reversible dilated cardiomyopathy
por: Laway, Bashir A., et al.
Publicado: (2010)

Hypothyroidism-induced reversible dilated cardiomyopathy
por: Rastogi, P, et al.
Publicado: (2018)

Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy
por: Karatolios, Konstantinos, et al.
Publicado: (2018)

Baseline Blood Pressure and Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy with Spontaneous Mechanical Alternans
por: Watanabe, Mitsuhiro, et al.
Publicado: (2022)

Endothelin Receptor Blocker Reverses Breast Cancer–Induced Cardiac Remodeling
por: Maayah, Zaid H., et al.
Publicado: (2023)

Left Ventricular Global Longitudinal Strain as a Predictor for Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy
por: Jung, In Hyun, et al.
Publicado: (2020)

T1 Map-Based Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Nonischemic Dilated Cardiomyopathy
por: Chang, Suyon, et al.
Publicado: (2023)

Reversible dilated cardiomyopathy caused by idiopathic hypoparathyroidism
por: Jung, Youn Joo, et al.
Publicado: (2013)

Cushing's Disease Presented by Reversible Dilated Cardiomyopathy
por: Aydoğan, Berna İmge, et al.
Publicado: (2015)

Adrenocortical Carcinoma Presenting as Reversible Dilated Cardiomyopathy
por: Abdulla, Mansoor C.
Publicado: (2018)

Dilated Cardiomyopathy in Hyperthyroidism can be Reversed with Treatment
por: Alasmari, Lama, et al.
Publicado: (2023)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics
por: Sammani, Arjan, et al.
Publicado: (2021)

Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension
por: Kostov, Krasimir, et al.
Publicado: (2021)

Plasma big endothelin-1 predicts new-onset atrial fibrillation after surgical septal myectomy in patients with hypertrophic cardiomyopathy
por: Song, Changpeng, et al.
Publicado: (2019)

D‐dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes
por: Huang, Liyan, et al.
Publicado: (2022)

Association of Big Endothelin-1 with Coronary Artery Calcification
por: Qing, Ping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_osl7u9qkr6pdinebrk50kstve6